Notable Labs Files for Chapter 7 Bankruptcy

Dow Jones

2024-10-15

By Stephen Nakrosis

Biotechnology company Notable Labs said Tuesday it had voluntarily filed for chapter 7 bankruptcy and will liquidate.

The company said its decision comes after considering strategic alternatives.

Last month, the company said it would pause implementation of a planned Phase 2 study of cancer drug Volasertib in relapsed/refractory acute myeloid leukemia. The company also said it was reducing its workforce and outside consultants by approximately 65%.

Notable said the court would appoint a trustee to administer the bankruptcy estates, adding the company and its subsidiaries will be liquidated.

Also on Tuesday, Notable said all members of its board resigned. In addition, Chief Financial Officer Scott McPherson, and Joseph Wagner, the company's chief scientific officer, were terminated, effective Oct. 8. Interim Chief Executive Officer Kaile Zagger was also terminated and will serve as an advisor to the company effective as of that date.

Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

(END) Dow Jones Newswires

October 15, 2024 06:50 ET (10:50 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2475471575"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2475471575\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2475471575?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-15 18:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2475471575","market":"other","top_or_hot":-1,"title":"Notable Labs Files for Chapter 7 Bankruptcy","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Stephen Nakrosis \n</p>\n<pre>\n \n</pre>\n<p>\n  Biotechnology company Notable Labs said Tuesday it had voluntarily filed for chapter 7 bankruptcy and will liquidate. \n</p>\n<p>\n  The company said its decision comes after considering strategic alternatives. \n</p>\n<p>\n  Last month, the company said it would pause implementation of a planned Phase 2 study of cancer drug Volasertib in relapsed/refractory acute myeloid leukemia. The company also said it was reducing its workforce and outside consultants by approximately 65%. \n</p>\n<p>\n  Notable said the court would appoint a trustee to administer the bankruptcy estates, adding the company and its subsidiaries will be liquidated. \n</p>\n<p>\n  Also on Tuesday, Notable said all members of its board resigned. In addition, Chief Financial Officer Scott McPherson, and Joseph Wagner, the company's chief scientific officer, were terminated, effective Oct. 8. Interim Chief Executive Officer Kaile Zagger was also terminated and will serve as an advisor to the company effective as of that date. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Stephen Nakrosis at stephen.nakrosis@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 15, 2024 06:50 ET (10:50 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Notable Labs Files for Chapter 7 Bankruptcy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNotable Labs Files for Chapter 7 Bankruptcy\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2024-10-15 18:50</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Stephen Nakrosis \n</p>\n<pre>\n \n</pre>\n<p>\n  Biotechnology company Notable Labs said Tuesday it had voluntarily filed for chapter 7 bankruptcy and will liquidate. \n</p>\n<p>\n  The company said its decision comes after considering strategic alternatives. \n</p>\n<p>\n  Last month, the company said it would pause implementation of a planned Phase 2 study of cancer drug Volasertib in relapsed/refractory acute myeloid leukemia. The company also said it was reducing its workforce and outside consultants by approximately 65%. \n</p>\n<p>\n  Notable said the court would appoint a trustee to administer the bankruptcy estates, adding the company and its subsidiaries will be liquidated. \n</p>\n<p>\n  Also on Tuesday, Notable said all members of its board resigned. In addition, Chief Financial Officer Scott McPherson, and Joseph Wagner, the company's chief scientific officer, were terminated, effective Oct. 8. Interim Chief Executive Officer Kaile Zagger was also terminated and will serve as an advisor to the company effective as of that date. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Stephen Nakrosis at stephen.nakrosis@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 15, 2024 06:50 ET (10:50 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2475471575","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2475471575","pubTimestamp":1728989400,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Biotechnology company Notable Labs said Tuesday it had voluntarily filed for chapter 7 bankruptcy and will liquidate.The company said its decision comes after considering strategic alternatives.Notable said the court would appoint a trustee to administer the bankruptcy estates, adding the company and its subsidiaries will be liquidated.Also on Tuesday, Notable said all members of its board resigned. In addition, Chief Financial Officer Scott McPherson, and Joseph Wagner, the company's chief scientific officer, were terminated, effective Oct. 8. Interim Chief Executive Officer Kaile Zagger was also terminated and will serve as an advisor to the company effective as of that date.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"Notable Labs根据美国破产法第7章申请破产","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NTBL":0.9},"content_text":"By Stephen Nakrosis \n\n\n \n\n\n  Biotechnology company Notable Labs said Tuesday it had voluntarily filed for chapter 7 bankruptcy and will liquidate. \n\n\n  The company said its decision comes after considering strategic alternatives. \n\n\n  Last month, the company said it would pause implementation of a planned Phase 2 study of cancer drug Volasertib in relapsed/refractory acute myeloid leukemia. The company also said it was reducing its workforce and outside consultants by approximately 65%. \n\n\n  Notable said the court would appoint a trustee to administer the bankruptcy estates, adding the company and its subsidiaries will be liquidated. \n\n\n  Also on Tuesday, Notable said all members of its board resigned. In addition, Chief Financial Officer Scott McPherson, and Joseph Wagner, the company's chief scientific officer, were terminated, effective Oct. 8. Interim Chief Executive Officer Kaile Zagger was also terminated and will serve as an advisor to the company effective as of that date. \n\n\n \n\n\n  Write to Stephen Nakrosis at stephen.nakrosis@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 15, 2024 06:50 ET (10:50 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}